Endocytic Function of von Hippel-Lindau Tumor Suppressor Protein Regulates Surface Localization of Fibroblast Growth Factor Receptor 1 and Cell Motility

Autor: Vincent Dammai, Tien Hsu, Nurgun Kose, Yair Adereth
Rok vydání: 2006
Předmět:
endocrine system diseases
Endocytic cycle
Biology
C-Mer Tyrosine Kinase
Kidney
urologic and male genital diseases
Endocytosis
Biochemistry
Article
Receptor
IGF Type 1

Dynamin II
Growth factor receptor
Cell Movement
Proto-Oncogene Proteins
Humans
Receptors
Platelet-Derived Growth Factor

Metastasis suppressor
Receptor
Fibroblast Growth Factor
Type 1

Epidermal growth factor receptor
Carcinoma
Renal Cell

neoplasms
Molecular Biology
Cells
Cultured

rab5 GTP-Binding Proteins
Dynamin
c-Mer Tyrosine Kinase
Fibroblast growth factor receptor 1
Receptor Protein-Tyrosine Kinases
Cell Biology
NM23 Nucleoside Diphosphate Kinases
Kidney Neoplasms
female genital diseases and pregnancy complications
Cell biology
ErbB Receptors
stomatognathic diseases
Von Hippel-Lindau Tumor Suppressor Protein
Nucleoside-Diphosphate Kinase
Mutation
biology.protein
Hypoxia-Inducible Factor 1
Zdroj: Journal of Biological Chemistry. 281:12069-12080
ISSN: 0021-9258
DOI: 10.1074/jbc.m511621200
Popis: The tumor suppressor VHL (von Hippel-Lindau protein) serves as a negative regulator of hypoxia-inducible factor-alpha subunits. However, accumulated evidence indicates that VHL may play additional roles in other cellular functions. We report here a novel hypoxia-inducible factor-independent function of VHL in cell motility control via regulation of fibroblast growth factor receptor 1 (FGFR1) endocytosis. In VHL null tumor cells or VHL knock-down cells, FGFR1 internalization is defective, leading to surface accumulation and abnormal activation of FGFR1. The enhanced FGFR1 activity directly correlates with increased cell migration. VHL disease mutants, in two of the mutation hot spots favoring development of renal cell carcinoma, failed to rescue the above phenotype. Interestingly, surface accumulation of the chemotactic receptor appears to be selective in VHL mutant cells, since other surface proteins such as epidermal growth factor receptor, platelet-derived growth factor receptor, IGFR1, and c-Met are not affected. We demonstrate that 1) FGFR1 endocytosis is defective in the VHL mutant and is rescued by reexpression of wild-type VHL, 2) VHL is recruited to FGFR1-containing, but not EGFR-containing, endosomal vesicles, 3) VHL exhibits a functional relationship with Rab5a and dynamin 2 in FGFR1 internalization, and 4) the endocytic function of VHL is mediated through the metastasis suppressor Nm23, a protein known to regulate dynamin-dependent endocytosis.
Databáze: OpenAIRE